UTMD News and Press, Utah Medical Products Inc. From 07/30/19

SALT LAKE CITY, July 30, 2019 (GLOBE NEWSWIRE) -- In the second calendar quarter (2Q) and first half (1H) of 2019, Utah Medical Products, Inc. (Nasdaq: UTMD) attained results which reflect that the Company remains on target to achieve its financial goals for year 2019 despite the apparent n...

Introduction The Dividend Champions list is a monthly compilation of companies which have consistently increased their annual dividend payouts, and the latest edition may be found here . However, since this list is only produced once per month, the data in it can quickly get out of date. Fu...

Introduction The Dividend Champions list is a monthly compilation of companies which have consistently increased their annual dividend payouts, and the latest edition may be found here . However, since this list is only produced once per month, the data in it can quickly get out of date. Fu...

Utah Medical Products (NASDAQ: UTMD ): Q1 GAAP EPS of $0.84. More news on: Utah Medical Products, Inc., Earnings news and commentary, Healthcare stocks news, Read more ...

SALT LAKE CITY, April 25, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- In the first calendar quarter (1Q) of 2019, Utah Medical Products, Inc. (Nasdaq: UTMD) attained results consistent with achieving its financial goals for year 2019 despite a negative comparison with 1Q 2018 results. ...

Utah Medical Products Inc. ( UTMD ) invents, innovates, designs, engineers, manufactures, and sells quality medical instruments to end-users and third party distributors for use in hospital and office settings. They also sell component parts to Original Equipment Manufacturers. Their four prod...

In June of 2015, I started a series of articles in which I highlight the stocks from the Dividend Champions list that have the highest and the lowest Percent Above Average Yield (PAAY) over the past year and over the past five years. PAAY is a measure of how much a stock is above (high PAAY, u...

Utah Medical Products (NASDAQ: UTMD ): Q4 Non-GAAP EPS of $0.94; GAAP EPS of $0.91. More news on: Utah Medical Products, Inc., Earnings news and commentary, Healthcare stocks news, Read more ...

SALT LAKE CITY, Jan. 31, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Excluding a large favorable adjustment correcting the U.S. repatriation tax (REPAT) on foreign subsidiary cash and cumulative earnings (E&P), Utah Medical Products, Inc. (Nasdaq: UTMD) concluded a solid year in 2018 i...

NEW YORK, Dec. 10, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Allegion PLC (NYSE:ALLE), Las Vegas Sands Corp. (NYSE:LVS), Select Income...